Home > Insider Trading > Filing (0001209191-10-056519)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
742112	Invacare Corp	IVC	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	952680965

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236982	Martin C Harris	One Invacare Way Elyria OH 44035		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2010-11-19	2,698	$22.68	8,298	No	4	M	Direct
Common Shares	Disposition	2010-11-19	409	$27.69	7,889	No	4	S	Direct
Common Shares	Disposition	2010-11-19	1,888	$27.65	6,001	No	4	S	Direct
Common Shares	Disposition	2010-11-19	200	$27.66	5,801	No	4	S	Direct
Common Shares	Disposition	2010-11-19	28	$27.64	5,773	No	4	S	Direct
Common Shares	Disposition	2010-11-19	328	$27.63	5,445	No	4	S	Direct
Common Shares	Disposition	2010-11-19	545	$27.62	4,900	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Stock Option (Right to Buy)	Disposition	2010-11-19	2,698	$0.00	2,698	$22.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2003-12-31	2013-02-05	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Stock Option (Right to Buy)	$0.00			30,779	30,779	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	30,779	30,779	Direct

Footnotes

No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 30,779 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 1994 Performance Plan and the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between February 6, 2003 and August 20, 2008, at exercise prices between $23.71 to $47.01 per share, will expire between February 6, 2013 and August 20, 2018 and became or will become exercisable between January 24, 2004 and September 30, 2012.